Recurrence of persistent polyclonal B lymphocytosis (PPBL) after rituximab treatment.

Wehr, C; Houet, L; Pantic, M; Gutenberger, S; Emmerich, F; Marks, R; Fisch, P; Warnatz, Klaus

Wehr, C; Houet, L; Pantic, M; Gutenberger, S; Emmerich, F; Marks, R; Fisch, P; Warnatz, Klaus.

Affiliation

Wehr C; Center for Chronic Immunodeficiency (CCI), University Medical Center Freiburg, University of Freiburg, Breisacherstrasse 117, 79106, Freiburg, Germany.

Ann Hematol ; 94(6): 1075-6, 2015 Jun.

Article in En | MEDLINE | ID: mdl-25638669

Subject(s)

Antibodies, Monoclonal, Murine-Derived/therapeutic use; Immunologic Factors/therapeutic use; Lymphocytosis/diagnosis; Lymphocytosis/drug therapy; Adult; Female; Humans; Recurrence; Rituximab; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Murine-Derived / Immunologic Factors / Lymphocytosis Limits: Adult / Female / Humans Language: En Journal: Ann Hematol Year: 2015 Document type: Article

Fulltext

XML

PubMed Links

Search on Google